Early research (Phase 1)Study completedNCT03473002
What this trial is testing
A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults
Who this might be right for
Antiviral ProphylaxisRespiratory Syncytial Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 21